The US Prostate Cancer business is one of the largest and strategically critical franchises within Pfizer Oncology, anchored by XTANDI, a multibillion‑dollar market‑leading therapy, and strengthened by a robust late‑stage pipeline asset Mevrometostat. The Director, XTANDI & Mevrometostat Patient Experience Lead will be responsible for driving best‑in‑class consumer and patient engagement strategies across two priority assets. The role will initially focus primarily on XTANDI (initial 80% XTANDI / 20% Mevrometostat split), with responsibility for Mevrometostat increasing over time as the asset advances toward an anticipated first indication launch in 2027. This leader will own the XTANDI US consumer strategy & tactical execution, serving as the primary counterpart to our Alliance Partner (Astellas) Consumer team, while simultaneously building the foundational end-to-end patient experience strategy for Mevrometostat to ensure US launch readiness and success. The role requires strong strategic, analytical, and cross‑functional leadership capabilities, as well as deep expertise in consumer/patient marketing within a regulated industry.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Number of Employees
5,001-10,000 employees